Advanced glycation end‐products impair Na+/K+‐ATPase activity in diabetic cardiomyopathy: Role of the adenosine monophosphate‐activated protein kinase/sirtuin 1 pathway
Authors:
- 28 January 2014
- journal article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 41 (2) , 127-133
Abstract
Summary: Decreased Na+/K+‐ATPase activity, and both sirtuin 1 (SIRT1) and adenosine monophosphate‐activated protein kinase (AMPK) have been reported to be involved in the development of diabetic cardiomyopathy (DCM). The present study aimed to investigate the advanced glycation end‐products (AGE) that impair Na+/K+‐ATPase stability by regulating the AMPK/SIRT1 pathway during progression of DCM. To study type 1 diabetic mellitus (T1DM), a disease model in rats was established by a single intraperitoneal injection of streptozotocin (STZ; 65 mg/kg), and neonatal rat cardiomyocytes were also cultured. Heart function was detected by Doppler, and SIRT1 and AMPK protein expression were detected by immunohistochemistry and western blotting. Na+/K+‐ATPase activity was also monitored. Using in vivo rat models of DCM, we showed that Na+/K+‐ATPase activity decreased when both AMPK and SIRT1 expression were downregulated. In vitro, AGE impaired Na+/K+‐ATPase activity and decreased the AMPK and SIRT1 expression. Sirtuin 1 overexpression increased Na+/K+‐ATPase activity. 5‐aminoimidazole‐4‐carboxamide‐3‐ribonucleoside (AICAR) upregulated SIRT1 expression and increased Na+/K+‐ATPase activity, which could be partially abolished by splitomicin. Our results suggest that the dysfunction of DCM is related to AGE‐induced Na+/K+‐ATPase activity impairment through a mechanism involving the AMPK/SIRT1 pathway.Keywords
This publication has 38 references indexed in Scilit:
- AMPK isoform expression in the normal and failing heartsJournal of Molecular and Cellular Cardiology, 2012
- Alteration of Forkhead Box O (Foxo4) Acetylation Mediates Apoptosis of Podocytes in Diabetes MellitusPLOS ONE, 2011
- Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injuryAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- AMPK and SIRT1: a long-standing partnership?American Journal of Physiology-Endocrinology and Metabolism, 2010
- Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Cardioprotective signaling to mitochondriaJournal of Molecular and Cellular Cardiology, 2009
- Na/K-ATPase—An Integral Player in the Adrenergic Fight-or-Flight ResponseTrends in Cardiovascular Medicine, 2009
- PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditureCurrent Opinion in Lipidology, 2009
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activityNature, 2009
- Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart FailureCirculation Research, 2009